Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation

[1]  A. Patapoutian,et al.  TRPA1 Contributes to Cold Hypersensitivity , 2010, The Journal of Neuroscience.

[2]  N. Ozaki,et al.  Upregulations of P2X3 and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats , 2010, PAIN®.

[3]  Pierangelo Geppetti,et al.  Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. , 2010, Journal of medicinal chemistry.

[4]  Yi Dai,et al.  Expression of transient receptor potential ankyrin 1 (TRPA1) in the rat trigeminal sensory afferents and spinal dorsal horn , 2010, The Journal of comparative neurology.

[5]  C. Loprinzi,et al.  Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice , 2010, Molecular pain.

[6]  S. Dib-Hajj,et al.  Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability , 2010, Molecular pain.

[7]  H. Si,et al.  Ursodeoxycholic acid switches oxaliplatin‐induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53‐caspase 8 pathway in HepG2 hepatocellular carcinoma , 2009, International journal of cancer.

[8]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[9]  M. Friedlander,et al.  Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. , 2009, Brain : a journal of neurology.

[10]  A. Kato,et al.  Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice , 2009, Neuroscience Letters.

[11]  J. Levine,et al.  Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. , 2009, The journal of pain : official journal of the American Pain Society.

[12]  L. Ellis,et al.  Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. , 2009, Cancer research.

[13]  A. Szallasi,et al.  TRP channels and pain. , 2009, Current pharmaceutical design.

[14]  D. Corey,et al.  TRPA1 Modulates Mechanotransduction in Cutaneous Sensory Neurons , 2009, The Journal of Neuroscience.

[15]  B. Undem,et al.  Nitrooleic Acid, an Endogenous Product of Nitrative Stress, Activates Nociceptive Sensory Nerves via the Direct Activation of TRPA1 , 2009, Molecular Pharmacology.

[16]  R. Vennekens,et al.  TRPA1 acts as a cold sensor in vitro and in vivo , 2009, Proceedings of the National Academy of Sciences.

[17]  Howard L McLeod,et al.  Platinum neurotoxicity pharmacogenetics , 2009, Molecular Cancer Therapeutics.

[18]  A. Kato,et al.  Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice. , 2009, Journal of pharmacological sciences.

[19]  D. Massi,et al.  Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. , 2008, The Journal of clinical investigation.

[20]  J. Levine,et al.  Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. , 2008, The journal of pain : official journal of the American Pain Society.

[21]  S. Jordt,et al.  TRPA1 is a major oxidant sensor in murine airway sensory neurons. , 2008, The Journal of clinical investigation.

[22]  D. Andersson,et al.  Transient Receptor Potential A1 Is a Sensory Receptor for Multiple Products of Oxidative Stress , 2008, The Journal of Neuroscience.

[23]  Shigeo Kobayashi,et al.  Activation of transient receptor potential ankyrin 1 by hydrogen peroxide , 2008, The European journal of neuroscience.

[24]  D. Henze,et al.  HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity , 2008, Molecular pain.

[25]  J. Gu,et al.  TRPM8 Mechanism of Cold Allodynia after Chronic Nerve Injury , 2007, The Journal of Neuroscience.

[26]  G. Aldini,et al.  Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls , 2007, Medicinal research reviews.

[27]  Michael Zhao,et al.  TRPA1 mediates formalin-induced pain , 2007, Proceedings of the National Academy of Sciences.

[28]  A. Basbaum,et al.  4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1 , 2007, Proceedings of the National Academy of Sciences.

[29]  B. Nilius,et al.  Neurophysiology: Channelling cold reception , 2007, Nature.

[30]  S. Catinella,et al.  Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. , 2007, American journal of respiratory cell and molecular biology.

[31]  S. Monfardini,et al.  Oxaliplatin-related neurotoxicity: how and why? , 2006, Critical reviews in oncology/hematology.

[32]  Clifford J. Woolf,et al.  TRPA1 Contributes to Cold, Mechanical, and Chemical Nociception but Is Not Essential for Hair-Cell Transduction , 2006, Neuron.

[33]  David Julius,et al.  TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents , 2006, Cell.

[34]  J. Grem,et al.  Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage‐gated sodium channels , 2005, British journal of pharmacology.

[35]  K. Bölcskei,et al.  Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice , 2005, Pain.

[36]  A. Gomtsyan,et al.  A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[37]  J. Ito,et al.  Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment , 2004, Acta oto-laryngologica.

[38]  T. Hickish,et al.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.

[39]  M. Floeter,et al.  Oxaliplatin‐induced neurotoxicity: Acute hyperexcitability and chronic neuropathy , 2004, Muscle & nerve.

[40]  D. McKemy,et al.  Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1 , 2004, Nature.

[41]  C. Maggi,et al.  Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[42]  Peter McIntyre,et al.  ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures , 2003, Cell.

[43]  P. Sadler,et al.  Novel Adducts of the Anticancer Drug Oxaliplatin with Glutathione and Redox Reactions with Glutathione Disulfide , 2003 .

[44]  M. Floeter,et al.  Acute oxaliplatin-induced peripheral nerve hyperexcitability. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  K. Rudolf,et al.  Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist , 2000, British journal of pharmacology.

[46]  F. Lévi,et al.  Oxaliplatin: pharmacokinetics and chronopharmacological aspects. , 2000, Clinical pharmacokinetics.

[47]  P. Blumberg,et al.  Vanilloid (Capsaicin) receptors and mechanisms. , 1999, Pharmacological reviews.

[48]  M. McKeage,et al.  Comparative Adverse Effect Profiles of Platinum Drugs , 1995, Drug safety.

[49]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.